Tanzania Travel Care and Prevention
For adults traveling to Tanzania, you must take malaria chemoprophylaxis with either atovaquone/proguanil or mefloquine (first-line options), ensure Yellow Fever vaccination, and implement rigorous mosquito bite prevention measures—these interventions directly reduce mortality from malaria and Yellow Fever, both of which carry 20-50% fatality rates when severe.
Malaria Prophylaxis (Critical - High Mortality Risk)
Tanzania is in sub-Saharan Africa where chloroquine-resistant falciparum malaria is widespread 1. The evidence clearly shows that compliance with chemoprophylaxis is essential—most deaths occur in those who do not comply fully 1.
First-Line Chemoprophylaxis Options:
Atovaquone/Proguanil:
- Preferred by 91.67% of European travel medicine experts for standard 2-week travel to sub-Saharan Africa 2
- Better tolerated with fewer neuropsychiatric effects than mefloquine
- Start 1-2 days before travel, continue throughout, and for 7 days after return
Mefloquine:
- Provides superior protection in areas with highly chloroquine-resistant malaria 1
- Start 1 week before departure (helps establish habit and identifies early side effects) 1
- Continue for 4 weeks after return 1
- Contraindications: History of convulsions, epilepsy, serious psychiatric disorder, or liver impairment 1
- Warning: Neuropsychiatric side effects (anxiety, depression, hallucinations) occur in 0.01% severely, but British experience suggests higher frequency; 70% occur within first 3 doses 1
Doxycycline (Alternative):
- Second-line option for those unable to take other agents 1
- Caution: Photosensitization can be severe—avoid excessive sun exposure 1
Critical Compliance Points:
- Start prophylaxis 1 week before departure to establish the habit and achieve therapeutic blood levels 1
- Continue for 4 weeks after returning to prevent breakthrough infections 1
- Most malaria deaths in travelers result from non-compliance 1
Yellow Fever Vaccination (Mandatory)
Yellow Fever vaccine is required for entry into Tanzania and is medically essential given the 20-50% mortality rate in severe disease 3.
- Recommended for all persons ≥9 months traveling to areas at risk for Yellow Fever virus transmission in Africa 3
- Must be administered at least 10 days before travel to meet entry requirements
- Provides protection against a disease with no treatment and high mortality 3
- Valid for life (single dose sufficient)
Mosquito Bite Prevention (Essential Layer of Protection)
All experts (100%) recommend mosquito repellents, and 95% recommend mosquito nets 2. This is the foundation of malaria prevention 4, 5.
Specific Measures:
Personal Protection:
- Apply DEET-containing repellents to exposed skin (follow manufacturer's recommendations, especially with children) 1
- Wear long-sleeved clothing and long trousers after sunset 1
- Impregnate cotton garments with DEET solution for additional protection 1
Accommodation:
- Sleep in properly screened or air-conditioned rooms 1, 3
- Use permethrin-impregnated mosquito nets (0.2 g/m² every 6 months) that reach the floor or tuck under mattress 1
- Spray rooms with knockdown insecticide before evening 1
- Use electric mats to vaporize synthetic pyrethroids or burn mosquito coils overnight 1
- Avoid electronic buzzers—they are not effective 1
Additional Vaccinations
Based on standard travel medicine practice 6, 4:
Routine Vaccinations (Update/Confirm):
- Tetanus-diphtheria (can be given immediately before travel) 7
- Measles-mumps-rubella
- Polio (booster if needed, can be given shortly before departure) 7
Travel-Specific Vaccinations:
- Hepatitis A (can be given immediately before travel—offers better protection than immunoglobulin) 7
- Typhoid (ideally 1-4 weeks before travel) 7
- Hepatitis B (if extended stay or high-risk activities; ideally start 1-4 weeks before) 7
Critical Safety Points
Seek immediate medical attention if fever develops during or after travel (up to 1 year after return) 1. Even with perfect prophylaxis, protection is not 100% 1.
Common Pitfall: Travelers often underestimate malaria risk or discontinue prophylaxis early. The evidence is unequivocal—compliance saves lives, and most deaths occur from non-compliance 1.
For vulnerable groups (pregnant women, children, chronic illness), specialized consultation is essential as recommendations differ 2, 8.